Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX
Holding AXDX?
Track your performance easily
AXDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.73 - $6.20
Previous Close$1.83
Volume63.88K
Average Volume (3M)67.42K
Market Cap
$46.65M
Enterprise Value$84.71M
Total Cash (Recent Filing)$20.91M
Total Debt (Recent Filing)$58.97M
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Feb 25, 2025EPS Estimate
-$0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.72
Shares Outstanding23,679,383
10 Day Avg. Volume72,359
30 Day Avg. Volume67,418
Standard Deviation0.26
R-Squared0.01
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.44
Price to Sales (P/S)3.81
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.11
Enterprise Value/Gross Profit33.22
Enterprise Value/Ebitda-1.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Accelerate Diagnostics News
PremiumCompany Announcements
Accelerate Diagnostics Reports Key Advances Amid Financial Challenges
PremiumCompany Announcements
Accelerate Diagnostics Unveils Executive Incentive Plan Linked to FDA Goals
PremiumCompany Announcements
Accelerate Diagnostics’ Shareholder Decisions at Annual Meeting
Ownership Overview
41.88% Insiders
1.89% Mutual Funds
5.63% Other Institutional Investors
48.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AXDX FAQ
What was Accelerate Diagnostics’s price range in the past 12 months?
Accelerate Diagnostics lowest stock price was $0.73 and its highest was $6.20 in the past 12 months.
What is Accelerate Diagnostics’s market cap?
Currently, no data Available
When is Accelerate Diagnostics’s upcoming earnings report date?
Accelerate Diagnostics’s upcoming earnings report date is Feb 25, 2025 which is in 108 days.
How were Accelerate Diagnostics’s earnings last quarter?
Accelerate Diagnostics released its earnings results on Nov 07, 2024. The company reported -$0.544 earnings per share for the quarter, missing the consensus estimate of -$0.471 by -$0.073.
Is Accelerate Diagnostics overvalued?
According to Wall Street analysts Accelerate Diagnostics’s price is currently Overvalued.
Does Accelerate Diagnostics pay dividends?
Accelerate Diagnostics does not currently pay dividends.
What is Accelerate Diagnostics’s EPS estimate?
Accelerate Diagnostics’s EPS estimate is -$0.46.
How many shares outstanding does Accelerate Diagnostics have?
Accelerate Diagnostics has 23,679,382 shares outstanding.
What happened to Accelerate Diagnostics’s price movement after its last earnings report?
Accelerate Diagnostics reported an EPS of -$0.544 in its last earnings report, missing expectations of -$0.471. Following the earnings report the stock price went down -7.107%.
Which hedge fund is a major shareholder of Accelerate Diagnostics?
Among the largest hedge funds holding Accelerate Diagnostics’s share is Oracle Investment Management Inc. It holds Accelerate Diagnostics’s shares valued at N/A.
---
Accelerate Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AXDX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 42.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-68.22%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-17.82%
Trailing 12-Months
Company Description
Accelerate Diagnostics
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
---
AXDX Earnings Call
Q3 2024
0:00 / 0:00
---
AXDX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---